Vyepti (eptinezumab)

pCPA File Number: 22136

Negotiation Status:

Concluded with an LOI

Indication(s):

Prevention of migraine

Sponsor/Manufacturer:

Lundbeck Canada Inc.

CADTH Project Number:

SR0743

pCPA Engagement Letter Issued:

2023-02-16

Negotiation Process Concluded:

2023-06-16